Sandvold, who holds a MSc in Pharmaceuticals, joined Pharmalink in May 2016. Her most recent position was as Head of Pharmaceutical Development at Orexo AB. Before joining Orexo in 2003, she held several positions at Pfizer.

Apart from Sandvold, Pharmalink has also appointed Nora Sjödin as Vice President Regulatory Affairs, Ann-Kristin Myde as Project Director and Liselotte Theorell as Quality Assurance and Drug Safety Director